Beginning in 2014, SAj has presented awards on an annual basis for SAj Most Impactful Paper Award, SAj Best Peer Reviewer Award, and SAj Most Downloaded Paper at the AMERSA conference. Each awardee receives a glass trophy in recognition of their contributions to SAj.
SAj Most Impactful Paper Award
The SAj Most Impactful Paper Award is given annually to a published paper within SAj with a designation of the most impact to the field of addiction science within the previous two years. This award is nominated and awarded by the SAj Editorial Team.
2023 | [Not awarded] | |
2022 | Holly Hagle, PhD | Hagle HN, Martin M, Winograd R, Merlin J, Finnell DS, Bratberg JP, Gordon AJ, Johnson C, Levy S, MacLane-Baeder D, Northup R, Weinstein Z, Lum PJ. Dismantling racism against Black, Indigenous, and people of color across the substance use continuum: A position statement of the association for multidisciplinary education and research in substance use and addiction. Subst Abus. 2021;42(1):5-12. PMID: 33465013 |
2021 | Rachel Simon | Simon R, Snow R, Wakeman S. Understanding why patients with substance use disorders leave the hospital against medical advice: A qualitative study. Subst Abus. 2020;41(4):519-525. PMID: 31638862 |
2020 | [Not awarded] | |
2019 | Joseph Palamar | Palamar JJ, Le A, Acosta P. Posting, texting, and related social risk behavior while high. Subst Abus. 2020;41(3):382-390. PMID: 31382869; PMCID: PMC7122951 |
2018 | Randi Sokol, MD, MPH, MMed | Sokol R, Albanese C, Chaponis D, Early J, Maxted G, Morrill D, Poirier G, Puopolo F, Schuman-Olivier Z. Why use group visits for opioid use disorder treatment in primary care? A patient-centered qualitative study. Subst Abus. 2018 Jan 2;39(1):52-58. PMID: 28723302 |
2017 | Mallika Mundkur, MD, MPH | Mundkur ML, Gordon AJ, Kertesz SG. Will strict limits on opioid prescription duration prevent addiction? Advocating for evidence-based policymaking. Subst Abus. 2017 Jul-Sep;38(3):237-238. PMID: 28632485 |
2016 | Miriam Komaromy, MD | Komaromy M, Duhigg D, Metcalf A, Carlson C, Kalishman S, Hayes L, Burke T, Thornton K, Arora S. Project ECHO (Extension for Community Healthcare Outcomes): A new model for educating primary care providers about treatment of substance use disorders. Subst Abus. 2016;37(1):20-4. PMID: 26848803; PMCID: PMC4873719 |
2015 | Jessica J. Black, PhD | Black JJ, Chung T. Mechanisms of change in adolescent substance use treatment: how does treatment work? Subst Abus. 2014;35(4):344-51. PMID: 24901750; PMCID: PMC4257904 |
2014 | Conrad L. Woolsey, PhD, CHES, CC-AASP | Woolsey CL, Barnes LB, Jacobson BH, Kensinger WS, Barry AE, Beck NC, Resnik AG, Evans MW Jr. Frequency of energy drink use predicts illicit prescription stimulant use. Subst Abus. 2014;35(1):96-103. PMID: 24588300 |
SAj Best Peer Reviewer Award
The SAj Best Peer Reviewer Award recognizes an external peer reviewer that, in the previous two years, provided narrative within their peer-reviews that gave feedback to authors that was thorough, considered the article within the context of current addiction literature, and provided specific recommendations to improve the paper. This award is nominated and awarded by the SAj Editorial Team.
2023 | Rebekah Halmo, MSW, LCSW and Adèle Morvannou, PhD |
2022 | [Not awarded] |
2021 | Frank Schwebel, PhD and Elena Stein, MS |
2020 | [Not awarded] |
2019 | Ana Holtey, DO |
2018 | Sara Bartel and Gwen T. Lapham. PhD, MPH, MSW |
2017 | Matthew Neuman, PhD |
2016 | Diana S. Hoover, PhD |
2015 | Jeffrey Baxter, MD |
2014 | Joanna L. Starrels, MD, MS |
SAj Most Downloaded Paper
The SAj Most Downloaded Paper Award is given to the paper with the most full-text downloads within the previous two years according to data from our publisher.
2023 | [Not awarded] | |
2022 | Viktoriya Broyan, MS | Broyan VR, Brar JK, Allgaier Student T, Allgaier JT. Long-term buprenorphine treatment for kratom use disorder: A case series. Subst Abus. 2022;43(1):763-766. PMID: 35112990 |
2021 | S.J. Bartel, BA | Bartel SJ, Sherry SB, Stewart SH. Self-isolation: A significant contributor to cannabis use during the COVID-19 pandemic. Subst Abus. 2020;41(4):409-412. PMID: 33044893 |
2020 | Traci C. Green, PhD, MSc | Green TC, Bratberg J, Finnell DS. Opioid use disorder and the COVID 19 pandemic: A call to sustain regulatory easements and further expand access to treatment. Subst Abus. 2020;41(2):147-149. PMID: 32314951 |
2019 | Stefan Kertesz, MD, MSc | Kertesz SG, Satel SL, DeMicco J, Dart RC, Alford DP. Opioid discontinuation as an institutional mandate: Questions and answers on why we wrote to the Centers for Disease Control and Prevention. Subst Abus. 2019;40(4):466-468. PMID: 31361588 |
2018 | Stefan Kertesz, MD, MSc | Kertesz SG. Turning the tide or riptide? The changing opioid epidemic. Subst Abus. 2017 Jan-Mar;38(1):3-8. PMID: 27858590 |
2017 | Stefan Kertesz, MD, MSc | Kertesz SG. Turning the tide or riptide? The changing opioid epidemic. Subst Abus. 2017 Jan-Mar;38(1):3-8. PMID: 27858590 |
2016 | Ingrid A. Binswanger, MD, MPH, MS | Binswanger IA, Gordon AJ. From risk reduction to implementation: Addressing the opioid epidemic and continued challenges to our field. Subst Abus. 2016;37(1):1-3. PMID: 26820257 |
2015 | Christian Hopfer, MD | Hopfer C. Implications of marijuana legalization for adolescent substance use. Subst Abus. 2014;35(4):331-5. PMID: 25127003; PMCID: PMC4308295 |
2014 | Lauren M. Broyles, PhD, RN | Broyles LM, Binswanger IA, Jenkins JA, Finnell DS, Faseru B, Cavaiola A, Pugatch M, Gordon AJ. Confronting inadvertent stigma and pejorative language in addiction scholarship: a recognition and response. Subst Abus. 2014;35(3):217-21. PMID: 24911031; PMCID: PMC6042508 |